A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapyCarlos Aguíar, Roberto Ferrari, Francesco Cosentino et al.|Atherosclerosis Supplements|2015Cited by 84
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John Wilding, John E. Anderson et al.|Metabolism|2024Cited by 76